Transgene is a publicly traded French biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer.
A pioneer in viral vectors engineering, we have one ambition: design innovative treatments in the fight against cancer.
Our approach uses the mechanisms of the immune response to enable the patient’s body to fight against disease.
Parc d'Innovation 400 Boulevard Gonthier d Andernach, 67405 Illkirch Graffenstaden Cedex – France
Jan. 12, 2001Stock exchange(s)